Additive Formula 3
Active substance: DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, ADENINE
SOLUTION · DEXTROSE MONOHYDRATE 1.1 g/100mL, TRISODIUM CITRATE DIHYDRATE .59 g/100mL, SODIUM CHLORIDE .41 g/100mL, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .28 g/100mL, CITRIC ACID MONOHYDRATE .042 g/100mL, ADENINE .03 g/100mL
United StatesActive
Marketing holder: Terumo BCT, Ltd
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXTROSE MONOHYDRATE · 1.1 g/100mL
- TRISODIUM CITRATE DIHYDRATE · .59 g/100mL
- SODIUM CHLORIDE · .41 g/100mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · .28 g/100mL
- CITRIC ACID MONOHYDRATE · .042 g/100mL
- ADENINE · .03 g/100mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9679-7c24-8bd3-1eaefa7ef2a9,01a1208c-9895-793e-9111-6709a1287329,01a1208c-bb5f-7e6a-a861-e4d043b92cb2,01a1208c-f5bf-70a6-b465-0c472c890815,01a1208c-f5d0-70f2-bfba-af72915ceeb8;count=73 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 14537-832
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 14537-832 · Verified 2026-10-09 · open in source